Koga Tomohiro, Torigoshi Takafumi, Motokawa Satoru, Miyashita Taichiro, Maeda Yumi, Nakamura Minoru, Komori Atsumasa, Aiba Yoshihiro, Uemura Takashi, Yatsuhashi Hiroshi, Ishibashi Hiromi, Eguchi Katsumi, Migita Kiyoshi
Clinical Research Center and Department of Rheumatology, NHO Nagasaki Medical Center, Omura, Japan.
FEBS Lett. 2008 Mar 5;582(5):579-85. doi: 10.1016/j.febslet.2008.01.022. Epub 2008 Feb 1.
In this study, we investigated the role of serum amyloid A protein (SAA) in the production of interleukin-6 (IL-6) using rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). Recombinant SAA stimulation induced the production of pro-inflammatory cytokine, IL-6, from RA-FLS. The signaling events induced by SAA included the activation of the mitogen-activated protein kineases, p38 and JNK1/2 and the activation of nuclear factor-kappa B (NF-kappaB). Inhibitor studies have shown SAA-induced IL-6 production to be down-regulated by NF-kappaB inhibition and partially inhibited by p38 or JNK inhibitors. Our findings demonstrate that SAA is a significant inducer of IL-6, which is critically involved in RA pathogenesis.
在本研究中,我们利用类风湿性关节炎成纤维细胞样滑膜细胞(RA-FLS)研究了血清淀粉样蛋白A(SAA)在白细胞介素-6(IL-6)产生中的作用。重组SAA刺激可诱导RA-FLS产生促炎细胞因子IL-6。SAA诱导的信号事件包括丝裂原活化蛋白激酶p38和JNK1/2的激活以及核因子-κB(NF-κB)的激活。抑制剂研究表明,NF-κB抑制可下调SAA诱导的IL-6产生,p38或JNK抑制剂可部分抑制该产生。我们的研究结果表明,SAA是IL-6的重要诱导剂,其在类风湿性关节炎发病机制中起关键作用。